Skip to content
Home/Companies/Biotech/Cellvie
CE

Cellvie

Biotech·United States·Active·1yr hold

Cellvie is a biotech company, headquartered in Switzerland.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Cellvie?

Cellvie is currently owned by Oscar & Paul (Beiersdorf Venture Capital) through Oscar & Paul Venture Capital Fund I (2020 vintage), since 2025. Across its history, Cellvie has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-07-03

Oscar & Paul (Beiersdorf Venture Capital)
Most recent investor
Oscar & Paul (Beiersdorf Venture Capital)
Oscar & Paul Venture Capital Fund I · 2020 · VC
2 ownership periods · full history below

Key facts

HQSwitzerland
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by KIZOO Technology Capital and Oscar & Paul (Beiersdorf Venture Capital) since 2021.
Co-invest · 2 holders · 2021 · present
KIZOO Technology Capital
KIZOO Technology CapitalActive
2021 · present · KIZOO Evergreen (Balance Sheet) · 2007 · Evergreen
MOIC
–
Oscar & Paul (Beiersdorf Venture Capital)
Oscar & Paul (Beiersdorf Venture Capital)Active
2025 · present · Oscar & Paul Venture Capital Fund I · 2020 · VC
MOIC
–

More from Oscar & Paul Venture Capital Fund I

Other portfolio companies in the same fund.

Turbine
Active
Deep TechUnited Kingdom· 2026
Melt&Marble
Active
BiotechSweden· 2025
ReVentas
Active
EnergyUnited Kingdom· 2025
Vincere Biosciences
Active
BiotechUnited States· 2025
DeepLife
Active
Deep TechFrance· 2024
Evommune
Exited 2025
BiotechUnited States· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings